Structural Genomix has tapped Kevin D’Amico to be its vice president of Synchrotron Radiation Research, a position that will have him operating from SGX’s facility at the Department of Energy’s Argonne National Laboratory, in Argonne, Ill.
D’Amico will work with Advanced Photon Source to oversee the design, development, and operation of a dual undulator beamline facility there. The facility, which SGX says will allow its scientists more quickly determine protein structures, is set to begin operating in November.
Before his appointment with the synchrotron research effort, which was announced on Sept. 25, D’Amico worked as a consultant for San Diego-based SGX as it prepped for constructing the facility.
Genset has appointed Daniel Cohen director general, scientific strategy, the company said on Sept. 24.
Cohen, who was previously chief scientific officer of the Genset Group, will be based at the company’s headquarters in central Paris. Andre Pernet, the firm’s CEO, will take over Cohen’s responsibilities as CSO.
Genset is a genomics-based pharmaceutical company that focuses on drug discovery in central nervous system and metabolic disorders.
Mats Bergström has joined Pyrosequencing as European sales director, the company said on Sept. 24.
Before joining Pyrosequencing, Bergström, 44, headed the PCR and consumables business unit of Applied Biosystems Europe, an Applera unit.
Pyrosequencing concentrates on genetic analysis tools based on its proprietary DNA sequencing technique.
Stratagene has hired Peter Wolstenholme to manage the company’s efforts in Europe, Stratagene said on Sept. 21.
Before joining the firm, Wolstenholme was vice president of sales and marketing for MWG-Biotech, a bioinformatics company.
Stratagene, based in La Jolla, Calif., develops and manufactures bioproducts and instruments for genomic and proteomic research.
Genome Therapeutics has named Martin Williams senior vice president of business development and marketing, infectious disease, the company announced on Sept. 5. Williams will concentrate on licensing and acquiring products, as well as commercializing products in infectious disease.
Williams comes to Genome Therapeutics from his post as vice president at Pentose Pharmaceuticals.
Christopher Becker has joined SurroMed as director of chemistry and mass spectrometry, the company said on Sept. 4.
Becker, 49, will head up SurroMed’s efforts in drug discovery and development using proteomics and orgeomics, the field surrounding low-molecular-weight organic compounds like peptides, lipids, and sugars.
Most recently, Becker served as senior director of proteomic technology at ThermoFinnigan Corp.
Promoted? Changing jobs? GenomeWeb wants to know. Help us keep track of you by e-mailing us at [email protected] . PEOPLE , a roundup of personnel comings and goings in genomics, appears each Wednesday at GenomeWeb.com.